PD-011: Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer (mCRC)
PD-011：伊马鲁单抗（一种抗氧化巨噬细胞迁移抑制因子 (oxMIF) 抗体）单独或与 5-氟尿嘧啶/亚叶酸钙 (5-FU/LV) 或帕尼单抗联合治疗转移性结直肠癌 (mCRC) 患者的安全性和有效性分析
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdw403
Lacouture, M E; Vincent, Picozzi; Caio, Rocha Lima; Vaibhav, Sahai; Diane, Simeone; Allyson, Ocean; Philip, Philip; Wasif, Saif; Aparna, Kalyan; Michael, Ondovik; Jack, Shiansong Li; Victoria, Manax; Julien, Taieb; Maria, Di Bartolomeo; Antonio, Cubillo; Jayne, Gurtler; Deborah, Wilbur; Huiling, Xiong; Jenny, Zhang; Jean-Marie, Cuillerot; Narikazu, Boku; Markus, Moehler; Eric, Van Cutsem; Lucjan, Wyrwicz; Keun-Wook, Lee; Fortunato, Ciardiello; Rosine, Guimbaud; Julien, Taieb; Jayne, Gurtler; Narikazu, Boku; Huiling, Xiong; Jenny, Zhang; Jean-Marie, Cuillerot; Yung-Jue, Bang; Saigí, M; Oliva, M; Aliste, L; Hormigo, G; Calvo, M; Serra, Ò; Farran, L; Miró, M; Boladeras Ana, M; Robles, J; Botargues Josep, M; de Lama, E; Pérez Martín Francisco, J; Paúles Maria, J; Creus, G; Galán, M; Mahalingam, D; Patel, M; Sachdev, J; Hart, L; Halama, N; Ramanathan, R; Sarantopoulos, J; Liu, X; Yazji, S; Jäger, D; Adib, D; Kerschbaumer, R; Yoon, M; Manzur, G; Starodub, A; Sivarajan, K; Wertheim, M; Thambi, P; Jones, M; Goel, S; Nemunaitis, J; Tsimberidou, A
巨噬细胞
肿瘤
肠癌
肿瘤免疫
巨噬细胞
MIF
细胞生物学
免疫/内分泌
